Dr. Hervey-Jumper is developing an AI-enabled surgical mapping platform – GlioSense – designed to help neurosurgeons identify speech-critical brain regions during glioma surgery without relying on traditional electrical stimulation. Using electrophysiology to analyze real-time brain activity recordings from patients with brain tumors, GlioSense can rapidly predict areas essential for language function, with the goal of improving surgical precision, reducing complications, and expanding access to safer brain tumor surgery.
